Table of Contents
Healthy future: Consumer demand for biologic drugs will stimulate industry revenue growth
Brand Name Pharmaceutical Manufacturing in the US
Operators in the Brand Name Pharmaceutical Manufacturing industry have grappled in recent years with one of the largest waves of drug patent expirations in history. As this so-called patent cliff occurred, many blockbuster drugs lost patent exclusivity, enabling low-price generic drugs to inundate the market. As a result, many brand name pharmaceutical manufacturers have contended with intensifying competition from generic manufacturers, cutting into revenue growth. Over the five years to 2021, investments in research and development that generate a high return will occur as many pharmaceutical manufacturers strengthen their drug pipeline with orphan drugs, which typically have a smaller disease population and lower requirements for the number of patients tested during clinical trials.
Pharmaceutical manufacturers develop prescription and over-the-counter products that are used to prevent or treat illnesses in humans or animals. Brand name drugs and medication have patent protection. This industry does not include nutritional supplement or cosmetic product manufacturers.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Generic Pharmaceutical Manufacturing in the US
Cosmetic & Beauty Products Manufacturing in the US
Drug, Cosmetic & Toiletry Wholesaling in the US
Pharmacies & Drug Stores in the US
Scientific Research & Development in the US
Biotechnology in the US
Global Pharmaceuticals & Medicine Manufacturing
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...